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Epidemiological Features of Aplastic Anaemia in Pakistan
S. N. Adil,G. N. Kakepoto,M. Khurshid ( Departments of Pathology, The Aga Khan University Hospital Karachi. ) 
I. A. Burney ( Departments of Medicine, The Aga Khan University Hospital Karachi. ) 
Abstract 
Objective: To complete the data on the demographic features of patients diagnosed to have aplastic
anemia at a single institution over a 7.5 years period.
Methods: Demographic information was retrieved from the patients medical records retrospectively as
well as prospectively of those patients who presented with features of aplastic anaemia. Their diagnosis
was confirmed by performing a complete blood count and bone marrow trephine.
Results: One hundred and forty four patients were diagnosed to have aplastic anemia; there were 106
males and 38 females. Their ages ranged from 2 to 75 years, with a median of 17 years, 112 (77.7%)
patients were below the age of 30 years. Severe aplastic anemia (SAA) was seen in 74 (51.4%), very
severe (VSAA) in 24 (16.7%) and non-severe aplastic anemia (NSAA) in 46(31.9%) patients. No
obvious cause could be established for 74.3%. Thirteen patients admitted using drugs known to cause
AA and one was a radiographer (9%). Out of 44 patients tested, 7 (15.9%) were found to have either
hepatitis B virus markers or antibody to hepatitis C at the time of diagnosis of AA. However it was
difficult to establish a cause and effect relationship with either drugs or viruses.
Conclusion:  Aplastic anaemia is found to occur mostly severe aplastic anaemia (JPMA 51:443,2001).
Introduction 
Epidemiological studies have shown that the presentation of aplastic anemia (AA) in the orient is
different from the west1-3. Studies from the far east also show that the disorder mainly affects the
younger population and there is a male preponderance2,4. Geographical variation in epidemiological
features of AA is thought mainly to be due to environmental rather than genetic factors1,5. However,
etiology largely remains unknown. Most studies describe idiopathic aplastic anemia as the largest
group”6. While information regarding the presenting data on AA is available form the west as well as
the far east, data from south Asia are scarce. Since environmental factors are thought to play a major
role in etiology of AA, it is conceivable that the presentation of the disease in south east Asia might be
different compared to what has been reported from else where. The following is a compilation of
clinico pathological features of patients in young males. The most common type was idiopathic
diagnosed to have AA at a tertiary referral center in Southern Pakistan.
Patients and Method 
The data were collected both retrospectively as well, as prospectively. The medical records of patients
diagnosed to have AA between January 1990 and December 1993 were traced from the Medical
Records section. The section uses International classification of diseases (lCD 9.0 version) database.
The attending physicians logged the diagnosis on to the face sheet. Between January 1994 and June
1996, the data were collected prospectively. Records were maintained for every patient diagnosed to
have AA in the laboratory, whether the patient was admitted to the hospital for management, or the
patient was only referred from elsewhere else for a bone marrow examination.
All patients had a complete blood count done on Coulter S+IV (Coulter Electronics, Florida, USA)
absolute neutrophil count (ANC) and reticulocyte count. The diagnosis of AA was established on the
basis of cellularity observed on bone trephine. Standard criteria of Cammita was employed to stage AA
into severe (SAA) and very severe aplastic anemia (VSAA)7.
Bone marrow smear was available in 73 of 144 cases in addition to bone trephine. Serology for
hepatitis B and C viruses (HBsAg and anti-HCV) was also checked in several patients. Acid hemolysis
(Ham’s) test, carried out routinely was available for analysis. Cytogenetic studies were not performed
in any case.
Results 
Over a 7.5 year period, 144 patients were diagnosed to have AA. Their ages ranged between 2 to 75
years (Median 17 years). One hundred and twelve (77.7%) were less than 30-years and 13 (9%) were
above 50 years. The peak incidence (45.8%) was in 11-20 years age group (Figure).
There were 106 males and 38 females. One hundred and two patients belonged to Karachi and 42 were
residents of rural Sindh, Baluchistan, Punjab and the Frontier province.
Figure Age groups in Aplastic Anaemia
The major reason to seek medical attention was a non-remitting fever. Sixty five (45.1%) patients had
more than one episode of fever. Forty four (30.6%) patients presented with bleeding; 17 bled from
gums 11 had epistaxis, 8 presented with purpura, per rectal bleeding occurred in 2 and 3 bled from
other sites. Nine patients had life-threatening bleeding. Thirty (20.8%) patients had symptomatic
anemia i.e. tiredness, shortness of breath and increasing pallor. Eight (5.5%) were diagnosed either
incidentally or during check up for unrelated medical problems. The duration of symptoms ranged from
2 to 360 days with a median of 60 days. As many as 30 (20.8%) patients had received transfusion on
more than one occasion before the diagnosis was established.
At the time of diagnosis the patients were also classified into prognostic groups using the standard
criteria. Forty six (31.9%) patients had NSAA, 74 (51.4%) had SAA and 24 (16.7%) were diagnosed to
have VSAA. The mean haemoglobin (Hb), total leukocyte count (TLC). ANC and platelet count for the
groups SAA and VSAA are shown in table 1.
It was difficult to define an etiology in each case. In 74.3% of the patients, no cause could be
established or suspected. Eight patients had a prior history of taking sulpha drugs. One patient had anti
tuberculous therapy (ATT) one year prior to diagnosis, 2 had a history of chloramphenicol use and 2
took unconventional medicines. One patient worked as a radiographer for more than three months prior
to the onset of symptoms. liowever, the vast majority of the subjects had symptomatic treatment by the
general practitioners before a final diagnosis of AA was established, and hence it was difficult to
establish a cause and effect relationship.
Viral serology was checked on 44 patients, 3 were found to be positive for Hepatitis B surface antigen
and four had antibody to hepatitis C virus. All these cases had been transfused before the diagnosis and
no direct cause and effect relationship could be established.
Discussion 
In our study, AA was seen to affect mainly the children, adolescent and young adults. One hundred
twelve (77.7%) patients were less than 30 years of age. In comparison with western studies, the median
age at the time of diagnosis was 17 years3,5,6. A bimodal peak was not observed in our patients as has
been reported in some studies from the West6. The results of our study are however consistent with
studies from Thailand2,4, Korea8 and China9 where 60-70% of the patients presented at less than 20
years of age. A small study from Northern Pakistan also suggested a higher frequency of AA in young
adults10. It is remains unclear as to why there is such a marked geographical difference in age
frequency in AA.
The male to female ratio of 2.8:1 observed in our study is also at variance with reports from the
West6,11.
However, the ratio is comparable to data from Asian countries, particularly those from China9 and
Bangkok2 and to earlier studies from Pakistan10. The age and sex distribution of patients from Japan
and Hong Kong is closer to Western patients12. The Japanese immigrants in Hawaii have pattern of AA
similar to that of Americans13.
In this study, we could not establish an etiological correlation with environmental factors. The largest
group was composed of the “idiopathic” entity, which comprised more than 74.3% of our cases. It is
possible that like other studies6,14,15 “idiopathic” group is actually a major group, however some points
merit discussion. It is plausible to think that the free availability of non-steroidal anti inflammatory
drugs, antibiotics, anticonvulsants, and anti malarials without prescriptions, may have played a bigger
role than has been discussed. Additionally, “traditional remedies” which are much more widely
available and are also cheaper may have had a positive etiologic role. Another explanation could be that
the patients generally have no record of their illnesses; a problem inherent to our social and cultural
circumstances and hence a correct estimate of various drugs causing AA could not be made. Only 9%
of patients gave a definite history of taking suspected drugs.
Hepatitis-associated AA typically occurs within six months of an acute attack of hepatitis16,17 of our
patients were detected to have viruses associated with hepatitis. 4 were positive for hepatitis B surface
antigen and 3 to hepatitis C antibody. All of these cases had received at least one blood transfusion
prior to presentation. We believe that at least in some patients this reactivity was secondary to
transfusions given to them for symtomatic anemia or bleeding. Studies from Taiwan and Thailand also
reveal a high incidence of hepatitis associated AA17,18. We however, did not screen our patients for
hepatitis A, a water-borne virus which has also been incriminated in the causation of AA19.
There are several limitations of the study. Firstly, the data were collected retrospectively for a period of
time, and although the medical charts were the source of information, it is possible that the relevant
drug history could not be obtained from every case. Also, since this part of the study dealt with patients
admitted to the hospital, the total number of patients diagnosed to have AA is actually an
underestimate. Another limitation of this study was the lack of availability of cytogenetic data.
Hypoplastic myelodysplastic study above the age of 50 years, when hypoplastic MDS is syndrome
(MDS) constitutes 20% of all the MDS in our country20. At times it is impossible to differentiate AA
from hyposplastic MDS on morphological grounds. However, there were only a few patients in this
seen more commonly20. If some of the patients were diagnosed to have AA erroneously, because of a
lack of availability of cytogenetic studies, the age incidence would likely to be even lower.
In conclusion these data show that AA is not an uncommon problem in our country. It usually affects
young males and majority have SAA. The etiology of AA remains uncertain.
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